Tuesday, May 27, 2014

The Motley Fool: Johnson & Johnson Focusing on Quality Over Quantity

On May 22, Johnson & Johnson (NYSE: JNJ  ) hosted an all-day analyst day for its medical device business. This meeting didn't really offer any major surprises, but did highlight management's intention to run this business with a focus on returns and scale and an understanding of where the company can (or cannot) likely earn attractive returns for shareholders. All told, this update was not especially bullish for Covidien (NYSE: COV  ) or Intuitive Surgical (NASDAQ: ISRG  ) , but it may stoke ongoing speculation as to additional areas where Johnson & Johnson may look to shrink or expand via M&A.

Follow this link for more:
Johnson & Johnson Focusing on Quality Over Quantity

No comments: